Hyperscan Proton Therapy System Offers Pinpoint Accuracy
By MedImaging International staff writers Posted on 14 May 2018 |

Image: The S250i proton therapy system with Hyperscan PBS (Photo courtesy of Mevion Medial Systems/MedStar Georgetown).
An innovative Proton Therapy System improves on existing scanning capabilities and enables clinicians to deliver conformal fields faster and with more precision than in the past.
The Mevion Medical Systems (Mevion; Littleton, MA, USA) S250i Proton Therapy System with Hyperscan pencil beam scanning (PBS) shapes the delivered radiation dose by precisely targeting tumors with sub-atomic particles. To improve accuracy and speed, a robotically controlled adaptive aperture proton multi-leaf collimator (pMLC) is used, which trims the edges of the beam to achieve sharp lateral dose gradients. This capability can deliver up to a three times sharper drop off in radiation at the delivery field edge, sparing healthy tissue and limiting unnecessary radiation to sensitive locations.
By reducing delivery times to less than five seconds, errors resulting from target tumor shifting under normal organ motion, such as breathing, can be reduced. Other features of the S250i include a gantry mounted superconducting synchrocyclotron, a six degree-of-freedom treatment couch, and advanced in-room image guidance that creates a three-dimensional (3D) representation of the tumor and relays the information to the proton therapy device. The computerized tomography (CT) based imager can also be used to modify treatment in response to changes in the patient’s anatomy, such as tumor shrinkage.
“Proton therapy is an advanced form of radiation that can destroy cancer cells. A machine called a cyclotron speeds up protons to two thirds the speed of light and they become highly charged,” said radiation oncologist Peter Ahn, MD, of MedStar Georgetown (Washington DC, USA), which inaugurated the first system worldwide in April 2018. “Because we can more tightly control the protons than we are able with traditional radiation, proton therapy can be given without damaging critical tissues and structures near the tumor because the beam conforms precisely to the tumor’s size and shape.”
“Delivering sharp field edges has been a real challenge for PBS, especially in shallow fields. In intracranial procedures, where critical structures are in close proximity to tumors at shallow depths, having the sharpest lateral penumbra is essential,” said Skip Rosenthal, VP of clinical education at Mevion. “The sharp penumbras of the adaptive aperture system have substantial benefits for these patients. In addition, the enhanced speed of Hyperscan PBS could enable greater confidence in treating thoracic tumors.”
Proton therapy is a precise form of radiotherapy (RT) that uses charged particles instead of x-rays. It can be a more effective form of treatment than conventional RT as it directs the beam more precisely, with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumors, for whom it appears to produce fewer side effects such as secondary cancers, growth deformity, hearing loss, and learning difficulties.
Related Links:
Mevion Medical Systems
The Mevion Medical Systems (Mevion; Littleton, MA, USA) S250i Proton Therapy System with Hyperscan pencil beam scanning (PBS) shapes the delivered radiation dose by precisely targeting tumors with sub-atomic particles. To improve accuracy and speed, a robotically controlled adaptive aperture proton multi-leaf collimator (pMLC) is used, which trims the edges of the beam to achieve sharp lateral dose gradients. This capability can deliver up to a three times sharper drop off in radiation at the delivery field edge, sparing healthy tissue and limiting unnecessary radiation to sensitive locations.
By reducing delivery times to less than five seconds, errors resulting from target tumor shifting under normal organ motion, such as breathing, can be reduced. Other features of the S250i include a gantry mounted superconducting synchrocyclotron, a six degree-of-freedom treatment couch, and advanced in-room image guidance that creates a three-dimensional (3D) representation of the tumor and relays the information to the proton therapy device. The computerized tomography (CT) based imager can also be used to modify treatment in response to changes in the patient’s anatomy, such as tumor shrinkage.
“Proton therapy is an advanced form of radiation that can destroy cancer cells. A machine called a cyclotron speeds up protons to two thirds the speed of light and they become highly charged,” said radiation oncologist Peter Ahn, MD, of MedStar Georgetown (Washington DC, USA), which inaugurated the first system worldwide in April 2018. “Because we can more tightly control the protons than we are able with traditional radiation, proton therapy can be given without damaging critical tissues and structures near the tumor because the beam conforms precisely to the tumor’s size and shape.”
“Delivering sharp field edges has been a real challenge for PBS, especially in shallow fields. In intracranial procedures, where critical structures are in close proximity to tumors at shallow depths, having the sharpest lateral penumbra is essential,” said Skip Rosenthal, VP of clinical education at Mevion. “The sharp penumbras of the adaptive aperture system have substantial benefits for these patients. In addition, the enhanced speed of Hyperscan PBS could enable greater confidence in treating thoracic tumors.”
Proton therapy is a precise form of radiotherapy (RT) that uses charged particles instead of x-rays. It can be a more effective form of treatment than conventional RT as it directs the beam more precisely, with minimal damage to surrounding tissue. Evidence is growing that protons can be effective in treating a number of cancers, in particular children and young people with brain tumors, for whom it appears to produce fewer side effects such as secondary cancers, growth deformity, hearing loss, and learning difficulties.
Related Links:
Mevion Medical Systems
Latest General/Advanced Imaging News
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
- Cutting-Edge Technology Combines Light and Sound for Real-Time Stroke Monitoring
- AI System Detects Subtle Changes in Series of Medical Images Over Time
- New CT Scan Technique to Improve Prognosis and Treatments for Head and Neck Cancers
- World’s First Mobile Whole-Body CT Scanner to Provide Diagnostics at POC
- Comprehensive CT Scans Could Identify Atherosclerosis Among Lung Cancer Patients
- AI Improves Detection of Colorectal Cancer on Routine Abdominopelvic CT Scans
- Super-Resolution Technology Enhances Clinical Bone Imaging to Predict Osteoporotic Fracture Risk
- AI-Powered Abdomen Map Enables Early Cancer Detection
- Deep Learning Model Detects Lung Tumors on CT
- AI Predicts Cardiovascular Risk from CT Scans
- Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans
- New Technology Provides Coronary Artery Calcification Scoring on Ungated Chest CT Scans
Channels
Radiography
view channel
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read more
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read moreMRI
view channel
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read moreUltrasound
view channel
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read more
Novel Imaging Method Enables Early Diagnosis and Treatment Monitoring of Type 2 Diabetes
Type 2 diabetes is recognized as an autoimmune inflammatory disease, where chronic inflammation leads to alterations in pancreatic islet microvasculature, a key factor in β-cell dysfunction.... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more